UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4985-4995

MAKI, Robert G

2010

Volltextzugriff (PDF)

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

The lancet oncology, 2017-11, Vol.18 (11), p.1493-1501

2017

Volltextzugriff (PDF)

Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition

Journal of clinical oncology, 2018-01, Vol.36 (2), p.210-216

2018

Volltextzugriff (PDF)

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

The Lancet (British edition), 2016-04, Vol.387 (10028), p.1629-1637

2016

Volltextzugriff (PDF)

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

Journal of clinical oncology, 2016-03, Vol.34 (8), p.786-793

2016

Volltextzugriff (PDF)

GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer

Journal of clinical oncology, 2015-06, Vol.33 (16), p.1849-1854

2015

Volltextzugriff (PDF)

Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment

Journal of clinical oncology, 2018-01, Vol.36 (2), p.194-201

2018

Volltextzugriff (PDF)

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

Oncoimmunology, 2020-01, Vol.9 (1), p.1747340

2020

Volltextzugriff (PDF)

A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites

Genes chromosomes & cancer, 2011-08, Vol.50 (8), p.644-653

2011

Volltextzugriff (PDF)

Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2018-04, Vol.36 (10), p.1020-1044

2018

Volltextzugriff (PDF)

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4541-4547

2011

Volltextzugriff (PDF)

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

Clinical cancer research, 2011-06, Vol.17 (12), p.4082-4090

2011

Volltextzugriff (PDF)

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Journal of clinical oncology, 2008-11, Vol.26 (33), p.5352-5359

2008

Volltextzugriff (PDF)

Gemcitabine and Docetaxel in Metastatic Sarcoma: Past, Present, and Future

The oncologist (Dayton, Ohio), 2007-08, Vol.12 (8), p.999-1006

Maki, Robert G.

2007

Volltextzugriff (PDF)

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Journal of clinical oncology, 2008-02, Vol.26 (4), p.626-632

2008

Volltextzugriff (PDF)

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-03, Vol.373 (9669), p.1097-1104

2009

Volltextzugriff (PDF)

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis

Cancer, 2012-03, Vol.118 (6), p.1649-1655

2012

Volltextzugriff (PDF)

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)

Cancer, 2008-02, Vol.112 (3), p.608-615

2008

Volltextzugriff (PDF)

Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors

Journal of clinical oncology, 2010-02, Vol.28 (5), p.835-840

2010

Volltextzugriff (PDF)

Trials and Tribulations in Rare Cancer Clinical Research

Journal of clinical oncology, 2024-03, Vol.42 (8), p.865-867

Maki, Robert G

2024

Volltextzugriff (PDF)

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

The oncologist (Dayton, Ohio), 2018-01, Vol.23 (1), p.62-70

2018

Volltextzugriff (PDF)

Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence

Journal of the American College of Surgeons, 2012-07, Vol.215 (1), p.53-59

2012

Volltextzugriff (PDF)

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

The lancet oncology, 2009-11, Vol.10 (11), p.1045-1052

2009

Volltextzugriff (PDF)

1 – 25 von 535

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(473)
Mit Volltextzugriff
(460)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(534)
Japanisch
(99)

Erscheinungsjahr

n.n

Thema

Science & Technology
(306)
Life Sciences & Biomedicine
(267)
Humans
(247)
Oncology
(189)
Female
(137)
Male
(127)
Adult
(121)
Middle Aged
(109)
Aged
(102)
Biological And Medical Sciences
(97)
Tumors
(93)
Medical Sciences
(85)
Treatment Outcome
(54)
Sarcoma
(52)
Adolescent
(45)
Aged, 80 And Over
(44)
Mutation
(43)
Antineoplastic Agents - Therapeutic Use
(42)
Chemotherapy
(42)
Animals
(39)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer

Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas

A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites

Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis

R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Gemcitabine and Docetaxel in Metastatic Sarcoma: Past, Present, and Future

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)

Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors

Trials and Tribulations in Rare Cancer Clinical Research

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma

Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

Suchergebnisse filtern